Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
This product is categorized as antacids, antiflatulents and anti-Ulcerants
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
 
        Subscribe To Our Newsletter & Stay Updated